in

Kai Havertz to Chelsea ‘confirmed’ with both clubs about ‘to sign the agreement’ » Chelsea News

It’s been a crazy day so far for Chelsea transfer news.

The good news keeps rolling in and Chelsea fans are struggling to keep up, and struggling to contain their excitement.

This morning it looked as though things really advanced for the Kai Havertz to Chelsea deal as a string of updates were released by a number of the top sources.

Kai Havertz to Chelsea, one step away and then… here we go! Total agreement to be reached on nest hours with Bayer Leverkusen. Last bid is going to be accepted. €80M + €20M add ons as final fee. Last details and paperworks time. 🔵 #CFC #Havertz #Chelsea

— Fabrizio Romano (@FabrizioRomano) August 24, 2020

Leverkusen will soon accept Chelsea’s offer for @kaihavertz29. The transfer is perfect. 5 years contract for Havertz. Total Transfer fee 100 Mio Euro including adds on @SPORTBILD @AxelHesse1 @ChelseaFC @bayer04_en

— Christian Falk (@cfbayern) August 24, 2020

Bayer Leverkusen were this morning on the brink of finalising the financial side of the deal and confirming the add on structures with Chelsea.

Now, the two clubs are about to sign the agreement on all the details and finally conclude the deal in it’s entirety, according to the very reliable Fabrizio Romano, and Christian Falk of BILD.

Confirmed. Chelsea and Bayer Leverkusen to sign the agreement for Kai Havertz for €100M add ons included (80-10-10). Five years contract – Lampard already spoke with Kai. Paperworks time between the two clubs to complete every detail. Here we go soon 🔵🏁 #CFC #Havertz https://t.co/2uW7jTywhl

— Fabrizio Romano (@FabrizioRomano) August 24, 2020

Havertz will join Chelsea for a fee of just over £90 million in total, with £20 million of that being add ons. So Chelsea will sign Havertz for an initial fee of around £72 million.

Havertz will be signing a 5-year contract at Chelsea!


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments